Oswaldo Cruz Foundation
Clinical trials sponsored by Oswaldo Cruz Foundation, explained in plain language.
-
New HIV prevention shot every 6 months could replace daily pills for At-Risk youth
Prevention Recruiting nowThis study tests a long-acting injection given every 6 months to prevent HIV, compared to daily pills, in 1500 young men who have sex with men, transgender, and non-binary people in Brazil. Participants choose their preferred method and are followed for 2 years to see how well th…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated May 26, 2026 08:12 UTC
-
HIV prevention goes to the people: rio study brings PrEP to vulnerable communities
Prevention Recruiting nowThis study aims to make HIV prevention easier for people in underserved communities in Rio de Janeiro, such as gay and bisexual men, transgender women, and sex workers. Instead of requiring visits to traditional clinics, the study offers HIV prevention pills (PrEP) directly in co…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated May 22, 2026 14:04 UTC
-
Pill after sex could slash STIs in High-Risk groups
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline shortly after sex (called doxy-PEP) can prevent bacterial STIs like syphilis, gonorrhea, and chlamydia. It involves 200 sexual and gender minorities in Rio de Janeiro who are living with HIV or taking PrEP. Participants c…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated May 18, 2026 12:09 UTC